These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5970684)

  • 21. Mechanism of action of adrenergic beta-receptor blocking agents in the prevention of cyclopropane adrenaline-evoked ventricular arrhythmias in the dog.
    Sharma PL; Narang RS
    Indian J Med Res; 1968 Aug; 56(8):1256-64. PubMed ID: 5711605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart].
    Arrigo L; Macrì I; Rigon-Macrì P
    Boll Soc Ital Biol Sper; 1971 Oct; 47(20):647-50. PubMed ID: 4401207
    [No Abstract]   [Full Text] [Related]  

  • 23. Myocardial and haemodynamic effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1971 Mar; 41(3):437-44. PubMed ID: 4396969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists.
    Hermansen K
    Br J Pharmacol; 1969 Mar; 35(3):476-86. PubMed ID: 5809739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cardiac action of beta-blocking agents. I. Influence of 1-(4'-nitrophenyl)-2-isopropyl-aminoethanol hydrochloride (1-INPEA)].
    Greggia A; Poggioli R
    Boll Soc Ital Biol Sper; 1968 Jun; 44(11):969-72. PubMed ID: 5687296
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta-blocking activity of the 2 isomers and of the racemic form of INPEA (N-isopropyl-p-nitrophenylethanolamine) on the isolated portal vein in the rat].
    Sirtori CR; Radice F; Berti F
    Boll Soc Ital Biol Sper; 1969 Jun; 45(11):765-8. PubMed ID: 5399946
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of beta-blocking agent Ko 592 in massive doses upon catecholamines in arterial tissue and plasma and peripheral blood flow in anesthetized dogs before and after electric stimulation of sympathetic ganglia.
    Terry EN; Clauss RH; Redisch W; Rouen L
    J Cardiovasc Surg (Torino); 1970; 11(2):146-50. PubMed ID: 4394166
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of adrenergic blocking drugs on central angiotensin effects.
    Severs WB; Summy-Long J; Daniels-Severs A; Connor JD
    Pharmacology; 1971; 5(4):205-14. PubMed ID: 4397328
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of adrenoceptor blocking agents on body temperature.
    Feldberg W; Saxena PN
    Br J Pharmacol; 1971 Nov; 43(3):543-54. PubMed ID: 4400528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac action of beta-blocking drugs. VI. dl-INPEA can be made capable of preventing the electrocardiographic effects of pitressin by use of aminophylline].
    Greggia A; Razzaboni G; Setti L
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1780-3. PubMed ID: 5733067
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenergic mechanisms in the development of hypothermic ventricular fibrillation in the isolated perfused heart of the cat.
    Falck B; Nielsen KC; Owman C; Persson H; Sporrong B
    Eur J Pharmacol; 1972 Jan; 17(1):66-74. PubMed ID: 4401435
    [No Abstract]   [Full Text] [Related]  

  • 34. [The 2-isopropylamino-1-(2-naphthyl) ethanol chloride as an inhibitor of beta-adrenergic receptors].
    Pedraz de Cabo J
    Arch Inst Farmacol Exp (Madr); 1966; 18(2):73-89. PubMed ID: 6004600
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
    Singh BN; Williams EM
    Br J Pharmacol; 1971 Sep; 43(1):10-22. PubMed ID: 4400181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
    Ablad B; Brogård M; Carlsson E; Ek L
    Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
    [No Abstract]   [Full Text] [Related]  

  • 37. Steric aspects of adrenergic drugs. XI. Interactions of dibenamine and beta adrenergic blockers.
    Patil PN; Tye A; May C; Hetey S; Miyagi S
    J Pharmacol Exp Ther; 1968 Oct; 163(2):309-19. PubMed ID: 4386625
    [No Abstract]   [Full Text] [Related]  

  • 38. Simulated alpha-blockade due to inhibition of release of nor-epinephrine by a beta-blocking agent Ko 592.
    Redisch W; Clauss RH; Terry EN; Rouen L
    J Cardiovasc Surg (Torino); 1970; 11(2):141-5. PubMed ID: 4394165
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.